Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
18 Feb 2026
See more Mediterra DataCenters to develop a 100% green-powered data center in BarcelonaMediterra DataCenters to develop a 100% green-powered data center in Barcelona
-
16 Feb 2026
See more US company Elian lays foundation stone for Barcelona plant-based protein expansionUS company Elian lays foundation stone for Barcelona plant-based protein expansion
-
13 Feb 2026
See more AstraZeneca’s Barcelona Hub ranked Top 5 in Europe by Financial TimesAstraZeneca’s Barcelona Hub ranked Top 5 in Europe by Financial Times
-
02 Feb 2026
See more UK semiconductor company Aion Silicon establishes its primary European design center in BarcelonaUK semiconductor company Aion Silicon establishes its primary European design center in Barcelona
